Author： Tressler Randall
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.72, Iss.16, 2012-11, pp. : 2051-2062
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Should penicillin remain treatment of choice for GABHS?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Access to resources
Recommend
Tenofovir Plus Didanosine as Nrti Backbone in HIV-Infected Subjects
Current Medicinal Chemistry, Vol. 13, Iss. 23, 2006-10 ,pp. :
Complete viral suppression by HIV treatment regimens not required?
Inpharma, Vol. 1, Iss. 1297, 2001-01 ,pp. :
Will patents hinder the progress made in HIV treatment?
Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. :
Kidney disease a barrier to HIV treatment?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. :